XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
137 hedge funds and large institutions have $1.66B invested in Acceleron Pharma in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $4.12M | Put options by funds: $4.95M
39% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 28
Holders
137
Holding in Top 10
6
Calls
$4.12M
Puts
$4.95M
Top Buyers
| 1 | +$58.6M | |
| 2 | +$18.4M | |
| 3 | +$9.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.36M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$7.7M |
Top Sellers
| 1 | -$34.2M | |
| 2 | -$16.6M | |
| 3 | -$13.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.48M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$6.37M |